13F HOLDINGS REPORT
5AM Venture Management, LLC
Quarter ended Q1 2024 · Filed May 15, 2024 · Accession 0001104659-24-061973
Total Value
$446.6M
Positions
26
Other Managers
0
Confidential Omitted
No
Holdings (26)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | ENLIVEN THERAPEUTICS INC | ELVN | 3,835,975 | $67.5M | 15.11% |
| 2 | ENTRADA THERAPEUTICS INC | TRDA | 4,408,379 | $62.5M | 13.99% |
| 3 | DIANTHUS THERAPEUTICS INC | DNTH | 1,242,029 | $37.3M | 8.34% |
| 4 | MERUS N V | N5749R100 | 548,825 | $24.7M | 5.53% |
| 5 | CELLDEX THERAPEUTICS INC NEW | CLDX | 497,270 | $20.9M | 4.67% |
| 6 | PRAXIS PRECISION MEDICINES I | PRAX | 340,000 | $20.7M | 4.65% |
| 7 | VIKING THERAPEUTICS INC | VKTX | 237,560 | $19.5M | 4.36% |
| 8 | PHARVARIS N V | PHVS | 797,600 | $18.4M | 4.13% |
| 9 | BIOHAVEN LTD | BHVN | 319,972 | $17.5M | 3.92% |
| 10 | AVIDITY BIOSCIENCES INC | 05370A108 | 665,555 | $17.0M | 3.80% |
| 11 | TYRA BIOSCIENCES INC | TYRA | 939,298 | $15.4M | 3.45% |
| 12 | VOR BIOPHARMA INC | VOR | 6,361,723 | $15.1M | 3.38% |
| 13 | MOONLAKE IMMUNOTHERAPEUTICS | MLTX | 282,313 | $14.2M | 3.18% |
| 14 | CENTESSA PHARMACEUTICALS PLC | CNTA | 1,245,000 | $14.1M | 3.15% |
| 15 | VIRIDIAN THERAPEUTICS INC | VRDN | 736,595 | $12.9M | 2.89% |
| 16 | SILENCE THERAPEUTICS PLC | SLNCF | 476,200 | $10.3M | 2.30% |
| 17 | ANAPTYSBIO INC | ANABV | 357,733 | $8.1M | 1.80% |
| 18 | ZENTALIS PHARMACEUTICALS INC | ZNTL | 490,000 | $7.7M | 1.73% |
| 19 | ADVERUM BIOTECHNOLOGIES INC | 00773U207 | 541,666 | $7.7M | 1.71% |
| 20 | RALLYBIO CORP | RLYB | 3,630,724 | $6.7M | 1.50% |
| 21 | GH RESEARCH PLC | GHRS | 572,665 | $6.1M | 1.37% |
| 22 | SCPHARMACEUTICALS INC | 810648105 | 1,200,647 | $6.0M | 1.35% |
| 23 | MERSANA THERAPEUTICS INC | 59045L106 | 1,305,000 | $5.8M | 1.31% |
| 24 | COGENT BIOSCIENCES INC | COGT | 790,440 | $5.3M | 1.19% |
| 25 | Q32 BIO INC | QTTB | 251,994 | $4.3M | 0.96% |
| 26 | CIDARA THERAPEUTICS INC | 171757107 | 1,134,511 | $1.0M | 0.23% |